Absence of Interferon-γ-Inducible Gene IGTP Does Not Significantly Alter the Development of Chagasic Cardiomyopathy in Mice Infected with Trypanosoma cruzi (Brazil Strain)

Journal of Parasitology

Volumn 89, Issue 6, 2003, Pages 1237-1239

  De Souza, A P ^a   Tang, B ^a   Tanowitz, H B ^a   Factor, S M ^a   Shtutin, V ^a   Shirani, J ^a   Taylor, G A ^b,c   Weiss, L M ^a   Jelicks, L A ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GUANOSINE TRIPHOSPHATASE; INDUCIBLY EXPRESSED GUANOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG;

CHAGAS DISEASE; GENETICS; PARASITE RESISTANCE; PARASITIC DISEASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TYPE; CHAGAS DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE COURSE; GENE; HEART DISEASE; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HOST RESISTANCE; IGTP GENE; IMMUNE RESPONSE; INFECTION RESISTANCE; LISTERIA MONOCYTOGENES; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASITE CONTROL; PARASITEMIA; PARASITOSIS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; TOXOPLASMA GONDII; TRYPANOSOMA CRUZI;

ANIMALS; BRAZIL; CHAGAS CARDIOMYOPATHY; GTP PHOSPHOHYDROLASES; IMAGE PROCESSING, COMPUTER-ASSISTED; INTERFERON TYPE II; MAGNETIC RESONANCE IMAGING; MALE; MICE; PARASITEMIA; TRYPANOSOMA CRUZI;

ANIMALIA; LISTERIA; LISTERIA MONOCYTOGENES; PROTOZOA; TOXOPLASMA GONDII; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0346998051     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.1645/GE-3185RN     Document Type: Article

References (24)

1. ABEL, L. C. J., L. V. RIZZO, B. IANNI, F. ALBUQUERQUE, F. BACAL, D. CARRARA, E. A. BOCCHI, H. C. TEIXEIRA, C. MADY, J. KALIL, AND E. CUNHA-NETO. 2001. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-γ response to Trypanosoma cruzi infection. Journal of Autoimmunity 17: 99-108.
2. ARNHOLDT, A. C., M. R. PIUVEZAM, D. M. RUSSO, A. P. LIMA, R. C. PEDROSA, S. G. REED, AND J. SCHARFSTEIN. 1993. Analysis and partial epitope mapping of human T cell responses to Trypanosoma cruzi cysteinyl proteinase. Journal of Immunology 151: 3171-3179.
3. BOEHM, U., L. GUETHLEIN, T. KLAMP, K. OZBEK, A. SCHAUB, A. FUTTERER, K. PFEFFER, AND J. C. HOWARD. 1998. Two families of GTPases dominate the complex cellular response to IFN-gamma. Journal of Immunology 161: 6715-6723.
4. -, T. KLAMP, M. GROOT, AND J. C. HOWARD. 1997. Cellular responses to interferon-γ. Annual Reviews of Immunology 15: 749-795.
5. CARDILLO, F., J. C. VOLTARELLI, S. G. REED, AND J. S. SILVA. 1996. Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: Role of NK cells. Infection and Immunity 64: 128-134.
6. CHANDRA, M., H. B. TANOWITZ, S. B. PETKOVA, H. HUANG, L. M. WEISS, M. WITTNER, S. M. FACTOR, V. SHTUTIN, L. A. JELICKS, J. CHAN, AND J. SHIRANI. 2002. Significance of inducible nitric oxide synthase in acute myocarditis caused by Trypanosoma cruzi (Tulahuen strain). International Journal for Parasitology 32: 897-905.
7. COLLAZO, C. M., G. S. YAP, S. HIENY, P. CASPAR, C. G. FENG, G. A. TAYLOR, AND A. SHER. 2002. The function of gamma interferon-inducible GTP-binding protein IGTP in host resistance to Toxoplasma gondii is Statl dependent and requires expression in both hematopoietic and nonhematopoietic cellular compartments. Infection and Immunity 70: 6933-6939.
8. DOS SANTOS, P. V., E. ROFFE, H. C. SANTIAGO, R. A. TORRES, A. P. MARINO, C. N. PAIVA, A. A. SILVA, R. T. GAZZINELLI, AND J. LANNES-VIEIRA. 2001. Prevalence of CD8 (+) alpha beta T cells in Trypanosoma cruzi-elicited myocarditis is associated with acquisition of CD62L(Low)LFA-1(High)VLA-4(High) activation phenotype and expression of IFN-gamma-inducible adhesion and chemoattractant molecules. Microbes and Infection 3: 971-984.
9. HALONEN, S. K., G. A. TAYLOR, AND L. M. WEISS. 2001. Gamma interferon-induced inhibition of Toxoplasma gondii in astrocytes is mediated by IGTP. Infection and Immunity 69: 5573-5576.
10. HIGUCHI, M. L. 1997. Chronic chagasic cardiomyopathy: The product of a turbulent host-parasite relationship. Revista do Instituto de Medicina Tropical de São Paulo 39: 53-60.
11. HUANG, H., J. CHAN, M. WITTNER, L. A. JELICKS, S. A. MORRIS, S. M. FACTOR, L. M. WEISS, V. L. BRAUNSTEIN, C. J. BACCHI, N. YARLETT, M. CHANDRA, J. SHIRANI, AND H. B. TANOWITZ. 1999. Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. Journal of Molecular and Cellular Cardiology 31: 75-88.
12. HUNTER, C. A., T. SLIFER, AND F. ARAUJO. 1996. Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on tumor necrosis factor alpha and gamma interferon. Infection and Immunity 64: 2381-2386.
13. JELICKS, L. A., M. CHANDRA, V. SHTUTIN, S. B. PETKOVA, B. TANG, G. J. CHRIST, S. M. FACTOR, M. WITTNER, H. HUANG, S. A. DOUGLAS, L. M. WEISS, P. D. ORLEANS-JUSTE, J. SHIRANI, AND H. B. TANOWITZ. 2002. Phosphoramidon treatment improves the consequences of chagasic heart disease in mice. Clinical Science (London) 103: 267S-271S.
14. -, J. SHIRANI, M. WITTNER, M. CHANDRA, L. M. WEISS, S. M. FACTOR, I. BEKIROV, V. L. BRAUNSTEIN, J. CHAN, H. HUANG, AND H. B. TANOWITZ. 1999. Application of cardiac gated magnetic resonance imaging in murine Chagas' disease. American Journal of Tropical Medicine and Hygiene 61: 207-214.
15. MORRIS, S. A., L. M. WEISS, S. FACTOR, J. P. BILEZIKIAN, H. TANOWITZ, AND M. WITTNER. 1989. Verapamil ameliorates clinical, pathologic and biochemical manifestations of experimental chagasic cardiomyopathy in mice. Journal of the American College of Cardiology 14: 782-789.
16. RIBEIRAO, M., V. L. PEREIRA-CHIOCCOLA, L. NIA, F. A. AUGUSTO FRAGATA, S. SCHENKMAN, AND M. M. RODRIGUES. 2000. Chagasic patients develop a type I immune response to Trypanosoma cruzi trans-sialidase. Parasite Immunology 22: 49-53.
17. ROMANHA, A. J., R. O. ALVES, S. M. F. MURTA, J. S. SILVA, C. ROPERT, AND R. T. GAZZINELLI. 2002. Experimental chemotherapy against Trypanosoma cruzi infection: Essential role of endogenous interferon-γ in mediating parasitologic cure. Journal of Infectious Diseases 186: 823-828.
18. SORACE, J., R. JOHNSON, D. HOWARD, AND B. DRYSDALE. 1995. Identification of an endotoxin and IFN-inducible cDNA: Possible identification of a novel protein family. Journal of Leukocyte Biology 58: 477-484.
19. TAYLOR, G. A., C. M. COLLAZO, G. S. YAP, K. NGUYEN, T. A. GREGORIO, L. S. TAYLOR, B. EAGLESON, L. SECREST, E. A. SOUTHON, S. W. REID, L. TESSAROLLO, M. BRAY, D. W. MCVICAR, K. L. KOMSCHLIES, H. A. YOUNG, C. A. BIRON, A. SHER, AND G. F. VANDE WOUDE. 2000. Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proceedings of the National Academy of Science of the United States of America 97: 751-755.
20. -, M. JEFFERS, D. A. LARGAESPADA, N. A. JENKINS, N. C. COPELAND, AND G. F. VANDE WOUDE. 1996. Identification of a novel GTPase, the inducibly expressed GTPase, that accumulates in response to interferon-γ. Journal of Biological Chemistry 271: 20399-20405.
21. -, R. STAUBER, S. RULONG, E. HUDSON, V. PEI, G. N. PAVLAKIS, J. H. RESAU, AND G. F. VANDE WOUDE. 1997. The inducibly expressed GTPase localizes to the endoplasmic reticulum, independently of GTP binding. Journal of Biological Chemistry 272: 10639-10645.
22. TORRICO, F., H. HEREMANS, M. T. RIVERA, M. E. VAN, A. BILLIAU, AND Y. CARLIER. 1991. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. Journal of Immunology 146: 3626-3632.
23. TRISCHMANN, T., H. TANOWITZ, M. WITTNER, AND B. BLOOM. 1978. Trypanosoma cruzi: Role of the immune response in the natural resistance of inbred strains of mice. Experimental Parasitology 45: 160-168.
24. WHO. 1997. Chagas' disease. Tropical disease research. Thirteenth program report. Geneva: UNDP/WB/TDR.